Kommentar
New partners for Luspatercept in β‐thalassemia
American Journal of Hematology · 2024
DOI: 10.1002/ajh.27362 ↗Kurz gefasst
Kommentar in der Zeitschrift American Journal of Hematology, 2024. Verfasst von Francesca Vinchi. Beteiligte Einrichtung: Iron Research Laboratory, New York Blood Center, New York, USA. Hauptthemen laut MEDLINE: beta-Thalassemia, Recombinant Fusion Proteins, Immunoglobulin Fc Fragments. Die Arbeit nennt 9 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
beta-ThalassemiaRecombinant Fusion ProteinsImmunoglobulin Fc FragmentsHumansActivin Receptors, Type II
Substanzen
luspaterceptRecombinant Fusion ProteinsImmunoglobulin Fc FragmentsActivin Receptors, Type II
Autor:innen und Institutionen
- Iron Research Laboratory, New York Blood Center, New York, USA.
- Dept. of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, USA.
ORCID-Profile: Francesca Vinchi
Zitieren
APA
Vinchi, F. (2024). New partners for Luspatercept in β‐thalassemia. American Journal of Hematology. https://doi.org/10.1002/ajh.27362
Vancouver
Vinchi F. New partners for Luspatercept in β‐thalassemia. American Journal of Hematology. 2024. doi:10.1002/ajh.27362
BibTeX
@article{Vinchi2024,
author = {Vinchi, Francesca},
title = {New partners for Luspatercept in β‐thalassemia},
journal = {American Journal of Hematology},
year = {2024},
doi = {10.1002/ajh.27362}
}
EUVIMED